Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.68

-2.4%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who started this subject	6/27/2001 4:38:48 PM
From: Ian@SI	of 52153

From Briefing.com... ICOS Corp (ICOS) 60.05 +0.05: CE Unterberg Towbin initiates coverage with a BUY rating; company is developing two potential billion-dollar blockbuster drugs: Cialis, a PDE5 inhibitor to treat erectile dysfunction, and Pafase, to treat sepsis; believes Cialis could be superior to Viagra; currently no approved therapies to reduce mortality resulting from sepsis; sets a price target of $74.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next